CVS(Aetna)


At a Glance

  • Revenues up $2B vs previous reported quarter
  • EBIDTA ip $600M
  • Both month close and moving average analysis show consistent price increase trend, likely driven by Aetna integration progress
  • Hiring below sector in August

Rolling 12 months financials

Year over year financials


Stock Performance

MA = moving average; GSPC= S&P 500

Analyst buy/sell recommendations

Insider sentiment for quarter- Neutral

Based on trading behaviors of company officers and directors trading in their own stock


Earnings Call Summary

No call transcript available at time of writing 


Other indicators

Innovation score - Outperforming sector

Based on R&D activities. 


Deeper reading



END OF REPORT

x